Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

[1]  Hiroaki Takayama,et al.  Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes , 2022, The Journal of Pharmacology and Experimental Therapeutics.

[2]  C. Chu,et al.  MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. , 2022, Cell metabolism.

[3]  S. Loosen,et al.  Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis , 2022, Hepatology.

[4]  Ding-Chieh Song,et al.  Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit. , 2022, Annals of hepatology.

[5]  T. V. Nguyen.  USP15 antagonizes CRL4CRBN-mediated ubiquitylation of glutamine synthetase and neosubstrates , 2021, Proceedings of the National Academy of Sciences.

[6]  Z. Du,et al.  Ubiquitin specific peptidase 1 promotes hepatic fibrosis through positive regulation of CXCL1 by deubiquitinating SNAIL. , 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[7]  W. Dai,et al.  Apigenin Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways , 2021, PPAR research.

[8]  Seok-Jun Kim,et al.  Galectin-1 accelerates high-fat diet-induced obesity by activation of peroxisome proliferator-activated receptor gamma (PPARγ) in mice , 2021, Cell death & disease.

[9]  R. Mirzayans,et al.  Do TUNEL and Other Apoptosis Assays Detect Cell Death in Preclinical Studies? , 2020, International journal of molecular sciences.

[10]  I. Goldstein,et al.  Protocol for Primary Mouse Hepatocyte Isolation , 2020, STAR protocols.

[11]  K. Lan,et al.  (pro)renin receptor knockdown attenuates liver fibrosis through inactivation of ERK/TGF- ?1/Smad3 pathway , 2020, Journal of Hepatology.

[12]  S. Friedman,et al.  Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis , 2020, Hepatology communications.

[13]  R. Schwabe,et al.  SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells , 2020, Cellular and molecular gastroenterology and hepatology.

[14]  R. Shiri-Sverdlov,et al.  NAFLD Preclinical Models: More than a Handful, Less of a Concern? , 2020, Biomedicines.

[15]  T. Osborne,et al.  Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue , 2020, Experimental & Molecular Medicine.

[16]  Jing Yang,et al.  USP15 potentiates NF-κB activation by differentially stabilizing TAB2 and TAB3. , 2020, The FEBS journal.

[17]  M. Lai,et al.  NAFLD: a multisystem disease that requires a multidisciplinary approach , 2019, Frontline Gastroenterology.

[18]  J. McManaman,et al.  Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions , 2019, The Journal of physiology.

[19]  D. Komander,et al.  Breaking the chains: deubiquitylating enzyme specificity begets function , 2019, Nature Reviews Molecular Cell Biology.

[20]  S. Akira,et al.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation , 2019, Journal of Virology.

[21]  Kyung-Hee Chun,et al.  A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling , 2019, Experimental & Molecular Medicine.

[22]  Chun Fang,et al.  Ubiquitin‐Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6 , 2018, Hepatology.

[23]  Ji-Hyun Kim,et al.  Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2 , 2018, Scientific Reports.

[24]  Y. Lee,et al.  Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation , 2018, The Journal of Biological Chemistry.

[25]  E. Yi,et al.  Post-translational modification of OCT4 in breast cancer tumorigenesis , 2018, Cell Death & Differentiation.

[26]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[27]  E. Bugianesi,et al.  Should we undertake surveillance for HCC in patients with NAFLD? , 2018, Journal of hepatology.

[28]  Feng Li,et al.  The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis , 2018, Nature Medicine.

[29]  Feng Li,et al.  The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis , 2017, Nature Medicine.

[30]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[31]  Kyung-Hee Chun,et al.  Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK) , 2017, BMB reports.

[32]  Zhi‐Gang She,et al.  USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity , 2017, Hepatology.

[33]  T. Takeuchi,et al.  Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease , 2017, FEBS open bio.

[34]  J. B. Moore,et al.  Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review , 2017, Proceedings of the Nutrition Society.

[35]  Jennifer L Mamrosh,et al.  p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates , 2017, Proceedings of the National Academy of Sciences.

[36]  R. Schwabe,et al.  Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. , 2016, Cell metabolism.

[37]  S. Chakrabarti,et al.  Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation , 2016, Diabetes.

[38]  A. Schoepfer,et al.  Therapy: Positioning of dilation in eosinophilic oesophagitis , 2016, Nature Reviews Gastroenterology &Hepatology.

[39]  Justin M. Reitsma,et al.  Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon. , 2016, Molecular cell.

[40]  A. D. Jones,et al.  Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[41]  H-W Lee,et al.  Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer , 2016, Oncogene.

[42]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[43]  Ivan Dikic,et al.  Ubiquitination in disease pathogenesis and treatment , 2014, Nature Medicine.

[44]  Peirong Yang,et al.  USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses , 2014, Nature Immunology.

[45]  E. Seki,et al.  Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice , 2014, Hepatology.

[46]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[47]  Donna D. Zhang,et al.  USP15 negatively regulates Nrf2 through deubiquitination of Keap1. , 2013, Molecular cell.

[48]  J. Seong,et al.  Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis , 2012, Proceedings of the National Academy of Sciences.

[49]  T. Luedde,et al.  Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage‐mediated chronic inflammation , 2012, Hepatology.

[50]  S. Park,et al.  Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. , 2010, Gastroenterology.

[51]  C. McClain,et al.  Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes , 2007, Hepatology.

[52]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[53]  K. Reue,et al.  Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[54]  S. Bonner-Weir,et al.  Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2. , 2000, Endocrinology.

[55]  Seok-Jun Kim,et al.  Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. , 2015, Endocrinology.